関連する実験動画

Updated: Feb 17, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

マルチオーム分析により,Bifidobacteriaceaeの因果的保護的役割が示され,炎症性腸疾患における主要な宿主遺伝子が関与していることが判明しました

Xia Leng^1,2, Pengfei Liu², Yi Gao²

¹Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, Jiangsu, China.

|February 16, 2026

まとめ

Bifidobacteriaceaeファミリーのバクテリアは,炎症性腸疾患 (IBD) に対して保護します. この研究は,宿主遺伝子であるLCT,MCM6,UBXN4を,この保護効果の重要な媒介者として特定し,IBDに対する新しい治療標的を提供している.

科学分野:

微生物学微生物学とは
遺伝学遺伝学とは
免疫学免疫学とは

背景:

腸内微生物群のディスバイオシスは,炎症性腸疾患 (IBD) の重要な特徴です.
IBDの原因となる特定の微生物とその作用機構は十分に理解されていません.
この研究は,IBDの因果的な微生物の駆動因子とその宿主媒介経路を特定することを目的としています.

研究の目的:

メンデルのランダム化 (MR) を使用してIBDリスクに因果的な影響を及ぼす特定の腸内微生物を特定する.
これらの微生物の影響を受ける遺伝子調節と免疫細胞の相互作用を含む宿主分子経路を解明する.
腸内細菌とIBDの病原性との間にメカニズム的なリンクを確立する.

主な方法:

ゲノム・ワイド・アソシエーション・スタディ (GWAS) データの2サンプルメンデルのランダム化 (MR) 分析.
IBD患者のトランスクリプトームのバイオ情報分析.
MRの発見をトランスクリプトミックのデータと統合し,宿主媒体を特定します.

主要な成果:

IBDに対するBifidobacteriaceaeファミリーの因果的保護効果が特定されました.
3つの宿主遺伝子であるLCT,MCM6,UBXN4が,潜在的な媒介者として特定されました.
LCTは保護的なニッチを生み出し,MCM6は病原性免疫細胞の増殖を促し,UBXN4はプロテオスタシスを調節する.

結論:

BifidobacteriaceaeはIBDに対する保護効果を与える.
特定の宿主遺伝子 (LCT,MCM6,UBXN4) は,Bifidobacteriaceae.の保護的役割を果たしています.
これらの発見は,宿主-微生物群の相互作用とIBDの潜在的な治療のためのメカニズム的枠組みを提供します.

キーワード:

ビフィドバクテリア科 (Bifidobacteriaceae) に属している.腸内微生物群 (gut microbiota) は,腸内微生物群 (gut microbiota) と呼ばれている.ホストと微生物群の相互作用免疫の調節免疫の調節とは炎症性腸疾患は,炎症性腸疾患で,炎症性腸疾患は炎症性腸疾患で,炎症性腸疾患は炎症性腸疾患で,炎症性腸疾患は炎症性腸疾患で,炎症性腸疾患は炎症性腸疾患で,炎症性腸疾患は炎症性腸疾患で,炎症性腸疾患は炎症性腸疾患で,炎症性腸疾患は炎症性腸疾患で.MCM6はMCM6で,MCM6はMCM6で,MCM6はMCM6で,メンデルのランダム化分析

さらに関連する動画

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Published on: April 21, 2015

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

関連する概念動画

Inflammatory Bowel Disease I: Ulcerative Colitis

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

Inflammatory Bowel Disease II: Crohn's Disease

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Chronic Bowel Disorders: Introduction

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...